SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-073024
Filing Date
2022-11-16
Accepted
2022-11-16 10:28:10
Documents
13
Period of Report
2022-11-11
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea168824-8k_bespoke.htm   iXBRL 8-K 20771
2 AMENDMENT NO. 1 TO INVENTORY EARN-OUT AGREEMENT ea168824ex10-1_bespoke.htm EX-10.1 6483
  Complete submission text file 0001213900-22-073024.txt   196210

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE bspk-20221111.xsd EX-101.SCH 3257
4 XBRL LABEL FILE bspk-20221111_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE bspk-20221111_pre.xml EX-101.PRE 22379
7 EXTRACTED XBRL INSTANCE DOCUMENT ea168824-8k_bespoke_htm.xml XML 3268
Mailing Address 2590 WALNUT ST. DENVER CO 80205
Business Address 2590 WALNUT ST. DENVER CO 80205 855-633-3738
Bespoke Extracts, Inc. (Filer) CIK: 0001409197 (see all company filings)

IRS No.: 204743354 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52759 | Film No.: 221393646
SIC: 2834 Pharmaceutical Preparations